JanOne Inc. (JAN)
| Market Cap | 10.45M |
| Revenue (ttm) | 36.14M |
| Net Income (ttm) | -12.14M |
| Shares Out | 1.87M |
| EPS (ttm) | -3.95 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 22 |
| Last Price | $5.63 |
| Previous Close | $5.65 |
| Change ($) | -0.03 |
| Change (%) | -0.44% |
| Day's Open | 5.60 |
| Day's Range | 5.45 - 5.73 |
| Day's Volume | 26,386 |
| 52-Week Range | 2.05 - 7.79 |
LAS VEGAS, Sept. 22, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relievi...
LAS VEGAS, Sept. 16, 2020 /PRNewswire/ -- JanOne Inc.
LAS VEGAS, Aug. 28, 2020 /PRNewswire/ -- JanOne Inc.
LAS VEGAS, Aug. 26, 2020 /PRNewswire/ -- JanOne Inc.
JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript
LAS VEGAS, Aug. 21, 2020 /PRNewswire/ -- JanOne Inc.
LAS VEGAS, Aug. 19, 2020 /PRNewswire/ -- JanOne Inc.
LAS VEGAS, Aug. 11, 2020 /PRNewswire/ -- JanOne Inc.
LAS VEGAS, Aug. 6, 2020 /PRNewswire/ -- JanOne Inc.
LAS VEGAS, Aug. 4, 2020 /PRNewswire/ -- JanOne Inc.
LAS VEGAS, July 30, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with...
LAS VEGAS, July 8, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with ...
LAS VEGAS, June 30, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with...
LAS VEGAS, June 25, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain r...
About JAN
JanOne develops treatments for conditions that cause severe pain. The company, through its non-addictive pain-relieving drugs, focuses on reduction for need of opioid prescriptions to treat disease associated pain that can lead to opioid abuse. Its lead candidate JAN101 provides slow-release formulation of sodium nitrite therapeutic for treatment of peripheral artery disease (PAD). The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976... [Read more...]
| Industry Waste Management | Founded 1976 |
| CEO Tony Isaac | Employees 199 |
| Stock Exchange NASDAQ | Ticker Symbol JAN |
Financial Performance
In 2019, JanOne's revenue was $35.10 million, a decrease of -4.61% compared to the previous year's $36.79 million. Losses were -$11.96 million, 113.3% more than in 2018.
Analyst Forecasts
The average 12-month stock price forecast for JanOne is 4.00, which is a decrease of -28.89% from the latest price.